Evaluación de ELISA F29 como marcador de eficacia del tratamiento etiológico en la enfermedad de Chagas
暂无分享,去创建一个
A. Ruiz | Enrique Arias | Diana L. Fabbro | Elsa B. Velázquez | N. Mendoza | M. Streiger | S. Denner | M. D. Barco | N. Amicone | C. Pravia | Nora Malagrino
[1] D. Engman,et al. Pathogenesis of Chagas heart disease: role of autoimmunity. , 2002, Acta tropica.
[2] A. Stoppani. QUIMIOTERAPIA DE LA ENFERMEDAD DE CHAGAS , 1999 .
[3] Carlos A. Vigliano,et al. PATOGENIA DE LA MIOCARDITIS CHAGASICA CRONICA HUMANA , 1999 .
[4] M. J. Toledo,et al. Trypanosoma cruzi: chemotherapy with benznidazole in mice inoculated with strains from Paraná state and from different endemic areas of Brazil. , 1997, Revista do Instituto de Medicina Tropical de Sao Paulo.
[5] E. Segura,et al. Trypanosoma rangeli and Trypanosoma cruzi: molecular characterization of genes encoding putative calcium-binding proteins, highly conserved in trypanosomatids. , 1996, Experimental parasitology.
[6] Simonne Almeida e Silva,et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection , 1996, The Lancet.
[7] A. Ouaissi,et al. Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease , 1995, Journal of clinical microbiology.
[8] D. Fabbro,et al. [Congenital Chagas disease in the city of Santa Fé. Diagnosis and treatment]. , 1995, Medicina.
[9] E. Segura,et al. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. , 1994, American heart journal.
[10] A. Capron,et al. Cloning and sequencing of a 24‐kDa Trypanosoma cruzi specific antigen released in association with membrane vesicles and defined by a monoclonal antibody , 1992, Biology of the Cell.
[11] P. Lizardi,et al. Apparent generation of a segmented mRNA from two separate tandem gene families in Trypanosoma cruzi. , 1985, Nucleic acids research.
[12] A. Prata,et al. Tratamento da Doença de Chagas pelo Nifurtimox (Bayer 2502) , 1975 .